Stem Cell Therapy International, Inc. Closes Merger With Histostem Ltd …
Stem Cell Therapy International, Inc. (OTCBB: SCII) announced that it has completed its merger with Histostem Ltd. of South Korea (”Histostem”), forming one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a …
[Read the full article here]Related News:
Stem Cell Therapy International completes merger with Histostem of South Korea
Stem Cell Therapy closes merger with Histostem
Stem Cell Therapy International, Inc. Announces Merger With Histostem and Launching of AmStem International, Inc.